VEA

Virtus ETF Advisers Portfolio holdings

AUM $75.7M
This Quarter Return
+4.29%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
AUM
$891M
AUM Growth
+$891M
Cap. Flow
+$760M
Cap. Flow %
85.31%
Top 10 Hldgs %
57.95%
Holding
371
New
107
Increased
50
Reduced
125
Closed
30

Sector Composition

1 Energy 74%
2 Healthcare 7.58%
3 Utilities 1.27%
4 Financials 0.09%
5 Technology 0.07%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
RNAC icon
101
Cartesian Therapeutics
RNAC
$261M
$598K 0.06% 38,458 -28,243 -42% -$439K
CRBP icon
102
Corbus Pharmaceuticals
CRBP
$115M
$585K 0.06% 77,428 -55,462 -42% -$419K
ACHN
103
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
$582K 0.06% 158,277 -113,149 -42% -$416K
PTCT icon
104
PTC Therapeutics
PTCT
$3.92B
$579K 0.06% 12,326 -8,814 -42% -$414K
INO icon
105
Inovio Pharmaceuticals
INO
$126M
$578K 0.06% 104,004 -74,361 -42% -$413K
ECYT
106
DELISTED
Endocyte, Inc. Common Stock
ECYT
$567K 0.06% 31,923 -23,422 -42% -$416K
HIFR
107
DELISTED
InfraREIT, Inc.
HIFR
$566K 0.06% +26,779 New +$566K
DNLI icon
108
Denali Therapeutics
DNLI
$2.23B
$559K 0.06% 25,718 -18,899 -42% -$411K
FLIN icon
109
Franklin FTSE India ETF
FLIN
$2.28B
$558K 0.06% +25,763 New +$558K
ONCE
110
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$554K 0.06% 10,162 +685 +7% +$37.3K
GTHX
111
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$552K 0.06% 10,561 -7,542 -42% -$394K
NVAX icon
112
Novavax
NVAX
$1.21B
$549K 0.06% 292,125 -208,839 -42% -$392K
RCKT icon
113
Rocket Pharmaceuticals
RCKT
$354M
$536K 0.06% 21,774 -15,976 -42% -$393K
DOVA
114
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
$532K 0.06% 25,375 +1,738 +7% +$36.4K
KERX
115
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$527K 0.05% 155,009 +10,445 +7% +$35.5K
VNQ icon
116
Vanguard Real Estate ETF
VNQ
$34.6B
$513K 0.05% 6,358 -6,597 -51% -$532K
SGMO icon
117
Sangamo Therapeutics
SGMO
$157M
$511K 0.05% 30,135 -21,556 -42% -$366K
ADAP
118
Adaptimmune Therapeutics
ADAP
$15.6M
$510K 0.05% 37,603 -27,618 -42% -$375K
ADVM icon
119
Adverum Biotechnologies
ADVM
$64.6M
$502K 0.05% 82,998 -60,953 -42% -$369K
CLVS
120
DELISTED
Clovis Oncology, Inc.
CLVS
$502K 0.05% 17,101 +1,171 +7% +$34.4K
PTLA
121
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$502K 0.05% 18,861 +1,271 +7% +$33.8K
ESPR icon
122
Esperion Therapeutics
ESPR
$448M
$501K 0.05% 11,297 -8,187 -42% -$363K
PVLA
123
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
$498K 0.05% 88,958 -63,592 -42% -$356K
BPMC
124
DELISTED
Blueprint Medicines
BPMC
$493K 0.05% 6,320 -4,520 -42% -$353K
CYTK icon
125
Cytokinetics
CYTK
$4.23B
$493K 0.05% 50,077 -35,803 -42% -$352K